NanoSphere Health Sciences Inc. Share Price

Equities

NSHS

CA63010P2098

Pharmaceuticals

Market Closed - Canadian Securities Exchange 20:11:23 03/05/2024 BST 5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for NanoSphere Health Sciences Inc. 0.00% +150.00%

Financials

Sales 2022 - Sales 2023 - Capitalization 77.02K 105K 6.14M
Net income 2022 - 0 0 Net income 2023 - 0 0 EV / Sales 2022 -
Net cash position 2022 55.01K 75.28K 4.39M Net cash position 2023 9.32K 12.75K 743K EV / Sales 2023 -
P/E ratio 2022
-0.67 x
P/E ratio 2023
-0.34 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 82.4%
More Fundamentals * Assessed data
Dynamic Chart
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
NanoSphere Health Sciences Inc. Auditor Raises 'Going Concern' Doubt CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
NanoSphere Health Sciences Inc. announced that it expects to receive CAD 0.234 million in funding CI
Nanosphere Health Sciences Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
NanoSphere Health Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
More news
Current month+66.67%
3 months+150.00%
6 months+66.67%
Current year+150.00%
More quotes
1 week
0.02
Extreme 0.015
0.03
1 month
0.02
Extreme 0.015
0.03
Current year
0.01
Extreme 0.01
0.03
1 year
0.01
Extreme 0.005
0.03
3 years
0.01
Extreme 0.005
0.70
5 years
0.01
Extreme 0.005
6.60
10 years
0.01
Extreme 0.005
23.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 16/11/17
Chairman 72 16/11/17
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 72 16/11/17
Chief Executive Officer - 16/11/17
Director/Board Member - 16/11/17
More insiders
Date Price Change Volume
03/05/24 0.025 0.00% 4,375
02/05/24 0.025 +66.67% 2,000
30/04/24 0.015 -40.00% 6,800

Delayed Quote Canadian Securities Exchange, May 03, 2024 at 08:11 pm

More quotes
NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Company’s operating division in the United States.
More about the company